The Stocks To Buy Now Tip Of The Week

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

ABcann Global is a Canadian Licensed Producer, Dedicated to Standardizing Pharmaceutical-grade Cannabis.

continue

If there is a stock you would like our team to review, let us know!
Submit Suggestion

Specializing in Micro-Cap and Small-Cap Stocks

“StocksToBuyNow” Newsletter

Every day there are thousands of stocks you can buy, but only a few will turn a big profit in a short amount of time. Our site is dedicated to finding stocks with action. No investor wants to be stuck with an underperforming, stagnating investment. Whether you follow us on social media, subscribe to our newsletter, or simply visit us once in a while to see the latest tip of the week, you will always find hot stocks you can put on your radar screen.

Get it Today! Simply provide your name and email below.

Stock Market Guide

How to Tell Which Stocks to Buy Now

We have put together a full guide to help micro-cap and small-cap
investors evaluate potential investments.

Claim Your Stock Market Guide

Get Instant Stock Alerts via Text

Every day hundreds of thousands in profits are made in the often ignored small-cap markets. GotStockTips™ is your place to receive real time text alerts.

Text stocks to 77948
or complete the form.

Although this service is free, message and data rates from carrier may apply. FAQs.


Name
Cell Number (US Only)
You will receive alerts from GotStockTips.
Get 6 messages per month.
Text HELP for help. Text STOP to cancel.
Msg&Data rates may apply.
Collected data is private and will not be sold
or shared with any other third party.

About Our Brand

We're constantly scanning the micro-cap and small-cap market for volume breakouts, hot press releases, and large percentage gainers getting the attention of the market.

Learn More >

Latest From Twitter

Follow us: @Buy_Stocks_Now

From Our Blog

India Globalization Capital, Inc. (NYSE: IGC) Reports Promising Progress of Cannabis-Based Alzheimer’s Drug Candidate

September 18, 2017

IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated $259 billion in 2017 It is considered America’s most expensive disease, projected to cost an estimated $259 billion in the […]

Rotate your device 90° to view site.